In this video, Dr. Mary Flynn and Dr. Preeti Reshamwala from Emory Health answer common questions patients ask about fatty liver disease- both NAFLD and NASH – how they are diagnosed, how it impacts patients’ health, and how some cases may be managed through lifestyle modification, medication and surgery.
A special thank you to support for this program made possible through an educational grant from Gilead.
*NAFLD has been newly renamed metabolic dysfunction-associated steatotic liver disease or MASLD. NASH has been newly renamed metabolic dysfunction associated steatohepatitis or MASH. Fatty liver disease has been newly renamed to steatotic liver disease or SLD. Learn more here: [ Ссылка ]
